Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rADAMTS-13 (SHP655) in Acquired TTP
NCT03922308Phase 2Completed
- Sponsor
- Takeda
- Start
- Oct 2019
- Primary completion
- Aug 2021
- Modality
- Replacement Enzymes
- Countries
- 7
01
Overview
A Phase 2 trial of Apadamtase alfa in thrombotic thrombocytopenic purpura (TTP), sponsored by Takeda. Started Oct 2019; status: completed.
02
Drugs
Apadamtase alfa
03
Conditions
thrombotic thrombocytopenic purpura (TTP)
Beyond the preview
Go deeper on NCT03922308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03922308.